Biogas Magazine | Edition 19 | 12
Biogas production from pharmaceutical Waste
M
ailhem Environment Private Limited has designed and constructed an anaerobic treatment plant for one of the bulk drug manufacturers, capable of treating fermentation broth samples containing high levels of BOD, COD & TSS. In this case, the split between biomass retention time and hydraulic retention
time is critical to the success of anaerobic treatment: a M-UASB reactor (our indigenous reactor) followed by an external sludge separation system with biomass re-circulation. This solution offers the advantages of High organic loading capacity & highly settleable granular biomass with ease to operate & maintain. Other advantages are
the small footprint and the lower anaerobic effluent TSS values, facilitating the aerobic post-treatment Anthem Bio-sciences Pvt Ltd manufactures drugs using Soya Flour, Peptone, Tetrose and Cultures like - Yeast, Fungus as a primary raw material. Fermentation is the core process used to con-
Sr. No
Tests
Unit
Sample – 01 Without Solvent
Sample – 02 With Solvent
1
Total Solids
%
11 . 9580
10 . 3362
2
Total Volatile Solids @ 550°C
%
10 . 5715
8 . 8298
3
COD
%
17 . 6268
41 . 7078
4
BOD (@ 27°C, 3 days)
%
7 . 5803
20 . 2405
5
Total Kjeldahl Nitrogen as (N)
%
1 . 0996
0 . 8617
6
Total Organic Carbon
%
4 . 7471
9 . 8171
